Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | AKT1 | P31749 | 2/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.45 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19033787 | 1.00 | HSP90AA1 (0.63) | HSP90AA1ALDH1A1TDP1MAPK1AKT1 | |
| SCHEMBL20677772 | 0.90 | HSP90AA1 (0.58) | HSP90AA1ALDH1A1TDP1MAPK1AKT1 | |
| SCHEMBL20677796 | 0.88 | HSP90AA1 (0.56) | HSP90AA1ALDH1A1MAPK1MAPTLMNA | |
| SCHEMBL3694184 | 0.87 | HSP90AA1 (0.54) | HSP90AA1ALDH1A1TDP1MAPTLMNA | |
| SCHEMBL3923560 | 0.87 | HSP90AA1 (0.54) | HSP90AA1ALDH1A1TDP1MAPTLMNA | |
| SCHEMBL9539946 | 0.87 | HSP90AA1 (0.54) | HSP90AA1ALDH1A1MAPK1MAPTLMNA | |
| SCHEMBL12426952 | 0.87 | HSP90AA1 (0.54) | HSP90AA1ALDH1A1TDP1MAPK1MAPT | |
| SCHEMBL11397350 | 0.87 | HSP90AA1 (0.54) | HSP90AA1ALDH1A1TDP1RECQLMAPT | |
| SCHEMBL19243283 | 0.84 | SMN1; SMN2 (0.53) | HSP90AA1ALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL21017537 | 0.82 | HSP90AA1 (0.50) | HSP90AA1ALDH1A1MAPTLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119868385-A | Application of pyrroloquinoline-polyamine analogue combined with doxorubicin in preparation of antitumor drugs | 河南大学 | 2025-04-25 | — | — | CN | claimed |
| CN-111163866-B | Enhancement of acetylene hydrogenation catalysts using phosphorus ylide | 切弗朗菲利浦化学公司 | 2023-05-09 | — | — | CN | claimed |
| EP-3681634-A1 | USE OF PHOSPHOROUS YLIDES TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS | Chevron Phillips Chemical Company LP (US) | 2020-07-22 | — | — | EP | claimed |
| CN-111163866-A | Use of phosphorus ylide to enhance acetylene hydrogenation catalysts | 切弗朗菲利浦化学公司 | 2020-05-15 | — | — | CN | claimed |
| US-10245583-B1 | Use of charge-containing molecules linked with covalent bonds to enhance acetylene hydrogenation catalysts | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2019-04-02 | — | — | US | claimed |
| WO-2019055451-A1 | USE OF PHOSPHOROUS YLIDES TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2019-03-21 | — | — | WO | claimed |
| US-20190076832-A1 | USE OF CHARGE-CONTAINING MOLECULES LINKED WITH COVALENT BONDS TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-03-14 | — | — | US | claimed |
| CN-101395237-B | Improvements in and relating to powder coating compositions crosslinked with non-cyanurate polyepoxides | HEXION SPECIALTY CHEMICALS RES | 2012-04-04 | — | — | CN | claimed |
| CN-101395237-A | Improvements in and relating to powder coating compositions crosslinked with non-cyanurate polyepoxides | HEXION SPECIALTY CHEMICALS RES (US) | 2009-03-25 | — | — | CN | claimed |
| EP-0918810-B1 | LOW TEMPERATURE CURE CARBOXYL TERMINATED POLYESTERS | RESOLUTION SPECIALTY MATERIALS (US) | 2005-03-09 | — | — | EP | claimed |
| US-6730812-B2 | BALL-MILLING AND SALT FORMATION, CATALYTIC REACTION IN ONE POT; CATALYST SELECTIVITY, EFFICIENCY, LOW TEMPERATURE, SIMPLIFICATION; FORMING UNSATURATED COMPOUNDS, 4-BROMOSTYRENE, ISOPROPENYLNAPHTHALENE/1-/ | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2004-05-04 | — | — | US | claimed |
| US-20030176740-A1 | Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2003-09-18 | — | — | US | claimed |
| WO-2003066548-A2 | SOLVENT-FREE MECHANOCHEMICAL PREPARATION OF PHOSPHONIUM SALTS, PHOSPHORUS YLIDES, AND OLEFINS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2003-08-14 | — | — | WO | claimed |
| US-5492983-A | COORDINATION CATALYST | ECP ENICHEM POLYMERES FRANCE (FR) | 1996-02-20 | — | — | US | claimed |
| US-12351686-B2 | Curable resin composition, dry film and cured product of same, and electronic component containing said cured product | TAIYO HOLDINGS CO., LTD. (JP) | 2025-07-08 | — | — | US | disclosed |
| CN-119868385-A | Application of pyrroloquinoline-polyamine analogue combined with doxorubicin in preparation of antitumor drugs | 河南大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-114269857-B | Curable resin composition, dry film and cured product thereof, and electronic component comprising the cured product | 太阳控股株式会社 | 2025-02-25 | — | — | CN | disclosed |
| US-4243683-A | INSECTICIDES, MITICIDES | MAY & BAKER LIMITED (GB) | 1981-01-06 | — | — | US | disclosed |
| US-4183870-A | Cyclopentane derivatives | MAY & BAKER LIMITED (GB) | 1980-01-15 | — | — | US | disclosed |
| US-4065620-A | ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190076832-A1 | USE OF CHARGE-CONTAINING MOLECULES LINKED WITH COVALENT BONDS TO ENHANCE ACETYLENE HYDROGENATION CATALYSTS | YWHAZ, SLC6A12, CHRNE | HSP90AA1 3289/4885ALDH1A1 2769/4885TDP1 3567/4885 |
| US-20030176740-A1 | Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins | CCR4, CCR1, CCR6 | HSP90AA1 4335/4885ALDH1A1 4791/4885TDP1 3762/4885 |
| US-10245583-B1 | Use of charge-containing molecules linked with covalent bonds to enhance acetylene hydrogenation catalysts | YWHAZ, SLC6A12, CHRNE | HSP90AA1 3289/4885ALDH1A1 2769/4885TDP1 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.